News

Veeva Systems (VEEV) is back in focus after the company lifted its fiscal 2027 guidance and signaled higher expected revenue and adjusted EPS, putting upcoming Q2 2027 results firmly on investor radar. See our latest analysis for Veeva Systems. At a share price of US$186.24, Veeva Systems has seen short term momentum pick up, with a 1 month share price return of 15.43% and a 3 month share price return of 15.58%. However, the 1 year total shareholder return is down 35.87%, suggesting the...

A number of stocks jumped in the afternoon session after investors appeared to rotate into oversold enterprise software names amid profit taking in chip stocks.

Don't give up on these stocks yet.

Veeva Systems Inc. (NYSE:VEEV) is one of the 10 Best SaaS Stocks to Buy According to Reddit. According to a June 29 report by Investing.com, Stifel reiterated its $230 price target and maintained a Buy rating on the stock following the company’s acquisition of Copli. Earlier on June 23, Veeva announced the acquisition of the […]

A number of stocks jumped in the afternoon session after Guggenheim's John DiFucci upgraded both Salesforce and ServiceNow to Buy, arguing the AI-disruption fear that gutted the sector during the year had pushed valuations too low. This was a valuation call from a skeptic, not an AI endorsement.

Veeva Systems (NYSE:VEEV) has been selected by UCB to deploy its Safety Suite across the biopharmaceutical company's global operations. The deal focuses on unifying UCB's worldwide pharmacovigilance activities on Veeva's integrated platform. This win expands Veeva's customer base among large global biopharmaceutical companies and highlights uptake of its safety offerings. Veeva Systems, known for its cloud software for life sciences, has been rolling out broader offerings that connect...

Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc.’s share was trading at $188.66 as of June 1st. VEEV’s trailing and forward P/E were 34.68 and 21.28 respectively according to Yahoo […]

Veeva Systems beats Q1 earnings and revenue estimates, raises fiscal 2027 guidance, and expands AI offerings as adoption of its software platforms expands.

Investing.com -- Veeva Systems Inc Class A (NYSE:VEEV) reported first-quarter results that exceeded analyst expectations, with adjusted earnings per share of $2.24 beating the consensus estimate of $2.14 by $0.10. Revenue reached $882.9 million, surpassing the $857.75 million estimate and marking a 16% increase from $759.0 million in the same quarter last year.

US benchmark equity indexes were lower intraday, while oil prices rose amid renewed hostilities in t

Veeva is on the verge of a technical breakout. The beaten-down biopharma software firm's growth outlook is strong, and it's a cash cow with a stellar balance sheet.

Phreesia (PHR) delivered earnings and revenue surprises of +150.00% and +0.51%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

MercadoLibre operates a leading e-commerce and fintech platform serving businesses and consumers across Latin America.

The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

This technology firm delivers SaaS and AI-driven workflow solutions for leading players in the property and casualty insurance sector.

VEEV expands Vault CRM adoption and AI capabilities with Roche and BioMarin partnerships as life sciences firms modernize workflows.

Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.

VEEV is expanding partnerships, growing Vault CRM adoption and boosting AI capabilities with its Ostro acquisition.

Client wins and data partnerships put Veeva’s workflow role in focus Veeva Systems (VEEV) just secured Smith+Nephew’s global quality management rollout on Veeva Quality Cloud, alongside a new Snowflake data partnership, putting fresh attention on how deeply its software sits in life sciences workflows. Smith+Nephew plans to use Veeva QualityDocs as a single source for quality controlled content, Veeva QMS to align processes globally, and Veeva Training to manage more than 500,000 annual...

Veeva Systems (NYSE:VEEV) recently announced a new collaboration with Smith+Nephew to centralize global quality management on Veeva Quality Cloud. The company also entered a partnership with Snowflake to connect the Veeva Vault Platform with Snowflake’s AI Data Cloud for life sciences data and analytics. These agreements position Veeva’s platforms more deeply within regulated, data intensive pharma and medtech workflows. Veeva Systems, trading at around $159.33, operates at the intersection...

Enovis (ENOV) delivered earnings and revenue surprises of +8.54% and +3.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Veeva’s upcoming S&P 500 inclusion could bring fresh index-driven demand to a high-margin software stock still trading far below its 52-week high.

Veeva Systems sits at the intersection of life sciences and enterprise cloud computing.

A number of stocks jumped in the morning session after strong earnings and upbeat forecasts from several peers boosted the broader software sector.